Ose Immunotherapeutics SA (OSE) Stock Price & News

All values in EUR	Sep 2024	Dec 2024
Revenue	431.00K	431.00K
Cost of goods sold	-	-
Cost of revenue	-	-
Research and development expenses	8.28M	8.28M
Total research and development expenses	-	-
Selling, general, and admin expenses	1.08M	1.08M
Operating expense	10.22M	10.22M
Total operating expenses	10.22M	10.22M
Operating income	-9.79M	-9.79M
Other non operating income	-611.00K	-611.00K
EBT including unusual items	-10.44M	-10.44M
EBT excluding unusual items	-10.53M	-10.53M
Income tax expense	-576.50K	-576.50K
Effective tax rate	5.52%	5.52%
Other operating expenses	41.00K	41.00K
Net income	-9.86M	-9.86M
Net profit margin	-2,288.86%	-2,288.86%
Earnings per share	-	-
Interest and investment income	571.00K	571.00K
Interest expense	-707.50K	-707.50K
Net interest expenses	-136.50K	-136.50K
Depreciation and amortization charges	-	-
EBITDA	-9.74M	-9.74M
Gain or loss from assets sale	-	-

Ask anything